AOL2h
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...
NHS Mounjaro warning as 90 per cent of people will be disappointed
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout
Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...
FiercePharma3h
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
Britain drug-cost watchdog says it will recommend Lilly obesity drug
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...
STAT2h
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
NHS gets 12 years to roll out new weight-loss drug
We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Comedian Jim Gaffigan’s Weight Loss Transformation Over the Years After Shedding 50 Pounds
Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...
'Long Starm of the law' and France 'in turmoil'
The paper says France is in "turmoil" and the crisis will "reverberate across Europe", noting that former Brexit negotiator ...
Health on MSN7h
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to Experts
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...